Interview
In conversation with
Piotr Orzechowski
Piotr Orzechowski is scaling clinical-grade triage with Infermedica, evolving from early symptom checkers to a Medical Guidance Platform that spans intake, triage, and follow-up. Think white-label, API-first technology adopted by payers, providers, and tech partners across dozens of countries—built on a decade of medical knowledge engineering and product refinement. The wager is disciplined: automate what’s routine, keep clinicians in the loop, and turn better navigation into access, efficiency, and trust at population scale.
AI will be able to prescribe and diagnose as accurately as doctors today over the phone.
The journey began with a simple idea—Akinator for symptoms—then moved through Bayesian prototypes, a white-label product, and finally an API strategy that let health systems embed guidance where patients already are. Flagship partnerships validated the model; COVID stress-tested it and accelerated multi-language deployment. The current focus is a modular platform (intake, triage, post-visit follow-up) that reduces operational burden while generating clean, explainable data for clinicians and payers. Orzechowski argues the sector needs two guardrails to keep momentum: marketing ethics (no inflated claims; evidence first) and regulatory courage—frameworks that enable safe AI adoption rather than stall it by design. Culturally, leaders should be unusually transparent and kind to innovators, because clear feedback can make or break early teams. And for talent, train broadly in AI and human skills; flexibility, communication, and purpose will differentiate what people—and platforms—can do next.
Lessons from Building Guidance at Scale:
From Demo to Platform
What we cover
-
How an API-first, white-label approach turned symptom checking into a scalable Medical Guidance Platform
-
Why evidence-anchored messaging and transparency are cultural non-negotiables in digital health marketing
-
What it will take for AI primary-care agents to be trusted—clinical oversight, regulation, and real-world outcomes
-
Where fundraising actually differs by stage—and when to look beyond Europe for speed and risk tolerance
-
Which capabilities leaders should build now—employee training in AI, strong soft skills, and feedback-rich, purpose-driven teams
Piotr Orzechowski is the founder and CEO of Infermedica, a leading health AI company dedicated to enhancing healthcare accessibility and efficiency through artificial intelligence. Piotr holds a Master of Science in Computer Science from the Technical University of Wrocław. His entrepreneurial journey includes participation in programs such as the Google for Startups Global Alumni Program, Google Leadership Academy, DreamIT Health, Plug and Play by Roche Diagnostics, InCredibles, and the Leadership Academy for Poland. Recognized as a thought leader in digital health, Piotr frequently speaks at industry conferences and has been honored with awards like Innovator of the Year by Healthcare Technology Magazine and the inclusion in the CB Insights’ Digital Health 150 List. Beyond his professional endeavors, he is a husband and father of two boys, and enjoys playing tennis and the guitar.
About
Piotr Orzechowski
